Biotechnology Jobs in the UK 2026: Demand, Salaries & Hiring Data

If you want the UK biotechnology jobs market reduced to numbers, this is the reference page. We have pulled together the most recent public data on vacancy volumes, salaries, regional hotspots, employer activity and the skills gap, and turned it into something you can scan in a couple of minutes. Every figure here is an estimate or a snapshot drawn from a named source, and the underlying market moves week to week, so treat these as a well-grounded picture rather than a guarantee.

The Short Answer

The UK life sciences sector employed roughly 359,600 people across about 6,170 businesses, generating around £146.9 billion in turnover, according to the Office for Life Sciences' 2023/24 bioscience statistics (the most recent comprehensive release). Biopharmaceutical employers account for roughly 45% of that workforce. Live biotech-specific vacancies in mid-2026 plausibly sit in the low-to-mid thousands nationally; single aggregators such as Glassdoor listed a few hundred at any one time, while broader job boards showed several hundred more in London alone. Median pay for a UK research scientist clusters around £35,000–£42,000, with bioprocess engineers nearer £48,000 and senior/principal scientists frequently above £60,000. Cambridge, Oxford and Stevenage dominate hiring. The headline tension: an estimated 70,000 new roles are needed by 2035 (BIA), against a persistent specialist skills shortage.

How Big Is the UK Biotech Jobs Market in 2026?

Biotech does not sit in a neat official category of its own, so the cleanest anchor is the wider life sciences estimate. The Office for Life Sciences (OLS) reported around 359,600 employees and £146.9 billion in turnover for 2023/24, split between biopharmaceuticals (about 45% of employment, 67% of turnover) and medical technology. Pure "biotechnology" — the genomics, cell and gene therapy, bioprocessing and synthetic-biology end of that spectrum — is a subset of those figures, which is why a single sector-wide vacancy count is genuinely hard to pin down.

For live demand, the honest answer is that estimates vary by source and method. In spring 2026, Glassdoor listed roughly 231 biotechnology vacancies UK-wide and around 227 in London, whereas aggregator Jooble showed close to 891 "biotech" roles in London alone — the gap reflecting how each platform defines and de-duplicates the sector. A defensible working estimate for genuinely biotech-specific live vacancies nationally is therefore in the low thousands at any given moment, with total annual hiring volumes several times higher once churn and replacement are included.

On year-on-year growth, the macro picture is mixed. Total UK vacancies across all sectors fell through late 2025 into early 2026 (ONS reported around 721,000 vacancies for December 2025–February 2026, down on the quarter), and biotech has not been immune to a tighter funding climate. UK biotech firms still raised roughly £1.9 billion in equity in 2025, which points to fewer but better-capitalised employers scaling teams — a pattern that supports steady, selective hiring rather than across-the-board expansion. We would caution against quoting a precise sector YoY vacancy growth figure; the credible read for 2026 is broadly flat-to-modest in headline volumes, with sharp growth concentrated in specialist niches.

What Do Biotech Jobs Pay in the UK?

Salaries depend heavily on sub-discipline, seniority and location, so the bands below are indicative midpoints synthesised from PayScale, Glassdoor, Prospects and recruiter guides (such as Adlib's biotech salary guide). Treat them as starting reference points, not offers — equity, bonus and London/cluster premiums can move real packages well outside these ranges.

Sub-role matters as much as title. Recruiter data consistently flags gene editing, bioinformatics, bioprocessing and regulatory affairs as the best-paid and hardest-to-fill specialisms, with some carrying double-digit premiums over generalist lab roles. Apply a rough location multiplier on top: recruiter guides put the South-East and the Oxford–Cambridge Arc at around +10% versus a national baseline, and London at roughly +20%.

Where Are the Biotech Jobs? Top UK Regions and Cities

UK biotech hiring is unusually concentrated geographically. The Oxford-to-Cambridge growth corridor is the centre of gravity, described by Cambridge Innovation Capital as home to around 3,000 knowledge-intensive companies. Cambridge alone hosts 600-plus life sciences companies — including AstraZeneca, GSK, Abcam and Illumina — across 30-plus science and technology campuses.

Stevenage deserves a specific mention: it has become one of Europe's leading sites for cell and gene therapy and advanced therapeutics, helped by the Cell and Gene Therapy Catapult and sustained government and industry investment. If your specialism is advanced therapies or bioprocessing, the Cambridge–Stevenage axis is where the densest demand sits in 2026.

Which Employers Are Hiring Biotech Talent?

The most active recruiters span established large-cap players and fast-scaling specialists. Naming names from recent 2026 listings and cluster reporting:

• AstraZeneca — large, continuous R&D hiring around Cambridge (for example, a Senior Research Scientist, Biologics Engineering role posted in May 2026).

• GSK — repeat hiring at Stevenage, including Principal Scientist positions in oncology data science (May 2026).

• Oxford Nanopore Technologies — sequencing scale-up hiring across Oxford and a new Birmingham manufacturing site, on the back of strong revenue growth.

• Abcam — Cambridge-based reagents and tools, a long-standing cluster employer.

• Illumina — sequencing presence within the Cambridge ecosystem.

Beyond these five, a long tail of SMEs and venture-backed scale-ups does much of the hiring; biotechnologyjobs.co.uk's own employer hotlists routinely identify 50-plus UK companies actively recruiting at any point. The practical takeaway: big names anchor the clusters, but a large share of openings — especially for early-career scientists — sit with smaller science-park firms that rarely top search results.

What Does Supply vs Demand Look Like?

This is where the market is most strained. Recruiter and industry surveys suggest around 65% of life sciences employers report difficulty hiring suitable candidates, with average time-to-fill stretching towards 78 days for specialist roles (figures circulated by sector recruiters; treat as directional rather than exact). On the demand side, the BIA and OLS project up to 70,000 net new roles by 2035, plus as many as 75,000 replacement hires as people retire or leave — a combined workforce requirement often summarised as around 145,000 skilled employees over the decade.

Bioprocessing is the sharpest pinch point. Sector analyses have pointed to bioprocessing skills demand approaching 10,000 roles, reflecting very large percentage growth from a small 2021 base as advanced-therapy manufacturing scales. Upstream/downstream process development, continuous bioprocessing and single-use technologies are all areas where supply visibly lags. The net effect is a "barbell" market in 2026: macro caution on headline headcount, combined with fierce competition for scarce specialists in cell and gene therapy, mRNA platforms, bioprocessing, bioinformatics and regulatory affairs.

How Common Is Remote or Hybrid Biotech Work?

Less common than in software, for an obvious reason: wet-lab and GMP manufacturing work is tied to regulated, equipment-heavy sites. The realistic split in 2026 is that the majority of biotech roles remain on-site or hybrid, with fully remote work concentrated in computational, data-science, regulatory, commercial and documentation functions. Job-board snapshots back this up — Indeed and similar platforms listed only a few hundred genuinely remote UK biotech roles at a time, a small fraction of total postings. We would avoid quoting a precise remote percentage, but a fair characterisation is that bench scientists should expect on-site or hybrid, while bioinformaticians, data scientists and regulatory specialists have meaningfully more flexibility.

Who Regulates and Represents the Sector?

Three bodies matter most for context. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, devices and clinical trials, which directly shapes demand for regulatory affairs and quality roles. The BioIndustry Association (BIA) is the main trade body and the source of much of the workforce-need data cited above. And UK Research and Innovation (UKRI), together with the Office for Life Sciences, funds and tracks much of the underlying research base and publishes the competitiveness and bioscience statistics that anchor sector estimates.

Where Is the Market Heading?

The short, hedged version: demand for specialist biotech skills looks structurally robust into the late 2020s even where headline vacancy counts stay flat. The combination of large projected workforce need (~70,000 net new roles by 2035), a concentrated and well-funded cluster geography, and acute bioprocessing and advanced-therapy shortages suggests that candidates with scarce, regulated-environment skills retain strong leverage — while generalist early-career competition stays high. None of that is guaranteed; funding cycles, policy and global capital flows could shift the picture, so revisit the numbers periodically.

Frequently Asked Questions: Biotechnology Jobs in the UK

How many biotechnology jobs are there in the UK in 2026?

There is no single official count for biotech specifically. The wider life sciences sector employs around 359,600 people (OLS, 2023/24), and live biotech-specific vacancies plausibly sit in the low thousands at any one time, depending on how each job board defines and de-duplicates the sector. Annual hiring volumes are considerably higher once churn is included.

What is the average biotech salary in the UK?

Indicative midpoints are roughly £33,000–£42,000 for a research scientist, around £48,000 for a bioprocess engineer, and £60,000-plus for senior or principal scientists, drawing on PayScale, Glassdoor and recruiter guides. Location premiums of about +10% (Oxford–Cambridge Arc) to +20% (London) apply on top, and specialist skills push packages higher.

Where are most UK biotech jobs located?

Hiring concentrates heavily in the Oxford-to-Cambridge corridor — Cambridge, Oxford and Stevenage in particular — plus London for commercial and clinical roles. Cambridge hosts 600-plus life sciences companies, while Stevenage is a leading European hub for cell and gene therapy and advanced manufacturing.

Which companies hire the most biotech staff in the UK?

Large, consistent recruiters include AstraZeneca, GSK, Oxford Nanopore Technologies, Abcam and Illumina, mostly across the Cambridge–Oxford–Stevenage clusters. A long tail of venture-backed scale-ups and science-park SMEs accounts for a large share of openings, especially at entry level.

Is there a skills shortage in UK biotech?

Yes, a persistent one. Around 65% of life sciences employers report hiring difficulties, with specialist roles taking roughly 78 days to fill (directional recruiter figures). Bioprocessing, cell and gene therapy, bioinformatics and regulatory affairs are the hardest-to-fill specialisms.

Can you work in biotech remotely in the UK?

Partly. Wet-lab and GMP manufacturing roles are tied to regulated sites and are largely on-site or hybrid. Fully remote opportunities are concentrated in bioinformatics, data science, regulatory affairs, commercial and documentation roles, and remain a minority of total postings.

Who regulates the UK biotechnology industry?

The MHRA regulates medicines, devices and clinical trials; the BioIndustry Association (BIA) is the sector's main trade body; and UKRI, with the Office for Life Sciences, funds research and publishes the official bioscience and competitiveness statistics that underpin most sector estimates.

Summary: UK Biotech Jobs Market Data 2026

UK biotech sits inside a life sciences sector employing around 359,600 people with about £146.9 billion in turnover (OLS, 2023/24), and the workforce is set to need roughly 70,000 net new roles by 2035 (BIA). Pay ranges from about £24,000 for entry roles to £60,000-plus for principal scientists, with the strongest premiums in bioprocessing, gene editing and regulatory affairs. Hiring is concentrated in Cambridge, Oxford, Stevenage and London, led by employers such as AstraZeneca, GSK and Oxford Nanopore. The defining feature of 2026 is a barbell market: cautious headline volumes alongside intense competition for scarce specialists. All figures here are estimates or snapshots and the market shifts continually, so verify against the latest data before making decisions.

Ready to act on the data? Browse current openings and set up alerts at biotechnologyjobs.co.uk — the UK's dedicated biotechnology job board.